Emulate Therapeutics, Inc.

CIK 1254348 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Emulate Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 8, 2025C0001254348-25-000003
Jul 31, 2024RW0001493152-24-029670
Sep 29, 2023S-1/A0001493152-23-034850
Sep 6, 2023S-1/A0001493152-23-031864
Jul 10, 2023S-1/A0001493152-23-024057
Jan 26, 2023S-1/A0001493152-23-002618
Jan 4, 2023S-1/A0001493152-23-000347
Sep 27, 2022S-1/A0001493152-22-026927
Aug 16, 2022S-10001493152-22-023239
Sep 20, 2019D0001572426-19-000110
Nov 19, 2018D/A0001572426-18-000086
Nov 20, 2017D0001572426-17-000041
May 19, 2017D0001572426-17-000016
Feb 23, 2017D/A0001572426-17-000007
Dec 24, 2015D0001572426-15-000134
Jun 23, 2015D0001572426-15-000076
Jul 21, 2014D/A0001572426-14-000041
Feb 10, 2014D0001572426-14-000009
Apr 13, 2010D0001254348-10-000003
Oct 26, 2004REGDEX9999999997-04-041617
Feb 5, 2004REGDEX9999999997-04-004461
Jul 14, 2003REGDEX9999999997-03-029321